Literature DB >> 6826100

Analgesic ingestion and other factors preceding relapse in ulcerative colitis.

D S Rampton, N I McNeil, M Sarner.   

Abstract

To investigate factors which predispose to relapse in patients with ulcerative colitis, we conducted a survey to compare the events occurring in the four weeks preceding the clinic attendance of 62 outpatients in remission with those taking place in the same period before the onset of relapse in 21 patients attending with active disease. The only event which occurred significantly more often in patients who subsequently relapsed was ingestion of paracetamol and other inhibitors of prostaglandin synthesis (76% (16/21) relapse vs 39% (24/62) remission, p less than 0 . 01). Recent upper respiratory tract infection (38% vs 26%) was not significantly more common in patients in relapse than in remission, and emotional stress, atopic events, antibiotic treatment, dietary indiscretions, foreign travel, and gastroenteritis were relatively rare in both groups. The surprisingly high prevalence of analgesic ingestion before relapse itself requires confirmation but does lend indirect support to the theory that colonic mucosal prostaglandin deficiency induces relapse in some patients with ulcerative colitis.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6826100      PMCID: PMC1419946          DOI: 10.1136/gut.24.3.187

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  12 in total

1.  Cytoprotection by prostaglandins.

Authors:  A Robert
Journal:  Gastroenterology       Date:  1979-10       Impact factor: 22.682

2.  Sulphasalazine is a potent inhibitor of prostaglandin 15-hydroxydehydrogenase: possible basis for therapeutic action in ulcerative colitis.

Authors:  J R Hoult; P K Moore
Journal:  Br J Pharmacol       Date:  1978-09       Impact factor: 8.739

Review 3.  Mode of action of aspirin-like drugs.

Authors:  S Moncada; J R Vane
Journal:  Adv Intern Med       Date:  1979

4.  Acute perforation of colonic diverticula associated with short-term indomethacin.

Authors:  S Coutrot; D Roland; J Barbier; P Van Der Marcq; M Alcalay; C Matuchansky
Journal:  Lancet       Date:  1978-11-11       Impact factor: 79.321

5.  Factors inducing relapse in inflammatory bowel disease.

Authors:  A S Mee; D P Jewell
Journal:  Br Med J       Date:  1978-09-16

6.  Letter: Rectal bleeding and indomethacin suppositories.

Authors:  N Levy; E Gaspar
Journal:  Lancet       Date:  1975-03-08       Impact factor: 79.321

7.  Drugs which inhibit prostaglandin biosynthesis.

Authors:  R J Flower
Journal:  Pharmacol Rev       Date:  1974-03       Impact factor: 25.468

8.  Prostaglandins, indomethacin, and ulcerative colitis.

Authors:  M Campieri; G A Lanfranchi; G Bazzocchi; C Brignola; A Benatti; S Boccia; G Labo'
Journal:  Gastroenterology       Date:  1980-01       Impact factor: 22.682

9.  Role of prostaglandins in ulcerative colitis. Enhanced production during active disease and inhibition by sulfasalazine.

Authors:  P Sharon; M Ligumsky; D Rachmilewitz; U Zor
Journal:  Gastroenterology       Date:  1978-10       Impact factor: 22.682

10.  Prostaglandin synthesis inhibitors in ulcerative colitis: flurbiprofen compared with conventional treatment.

Authors:  D S Rampton; G E Sladen
Journal:  Prostaglandins       Date:  1981-03
View more
  31 in total

Review 1.  Gastrointestinal complications of nonsteroidal anti-inflammatory drugs.

Authors:  R R Babb
Journal:  West J Med       Date:  1992-10

2.  Colitis associated with ibuprofen.

Authors:  D Clements; G T Williams; J Rhodes
Journal:  BMJ       Date:  1990-10-27

3.  Do non-steroidal anti-inflammatory drugs increase colonic permeability?

Authors:  A P Jenkins; D R Trew; B J Crump; W S Nukajam; J A Foley; I S Menzies; B Creamer
Journal:  Gut       Date:  1991-01       Impact factor: 23.059

4.  Systematic review with meta-analysis: association between acetaminophen and nonsteroidal anti-inflammatory drugs (NSAIDs) and risk of Crohn's disease and ulcerative colitis exacerbation.

Authors:  O O Moninuola; W Milligan; P Lochhead; H Khalili
Journal:  Aliment Pharmacol Ther       Date:  2018-04-05       Impact factor: 8.171

5.  Relapse of inflammatory bowel disease associated with use of nonsteroidal anti-inflammatory drugs.

Authors:  Angela M Meyer; Nizar N Ramzan; Russell I Heigh; Jonathan A Leighton
Journal:  Dig Dis Sci       Date:  2006-01       Impact factor: 3.199

6.  Noninfectious colitides: collagenous colitis, lymphocytic colitis, diversion colitis, and chemically induced colitis.

Authors:  Amy J Thorsen
Journal:  Clin Colon Rectal Surg       Date:  2007-02

Review 7.  Do non-steroidal anti-inflammatory drugs cause exacerbations of inflammatory bowel disease?

Authors:  Linda A Feagins; Byron L Cryer
Journal:  Dig Dis Sci       Date:  2010-02       Impact factor: 3.199

Review 8.  Non-steroidal anti-inflammatory drug-induced colitis.

Authors:  J L Faucheron; R Parc
Journal:  Int J Colorectal Dis       Date:  1996       Impact factor: 2.571

9.  Protective effect of metronidazole on uncoupling mitochondrial oxidative phosphorylation induced by NSAID: a new mechanism.

Authors:  A Z Leite; A M Sipahi; A O Damião; A M Coelho; A T Garcez; M C Machado; C A Buchpiguel; F P Lopasso; M L Lordello; C L Agostinho; A A Laudanna
Journal:  Gut       Date:  2001-02       Impact factor: 23.059

10.  Ulcerative colitis in a husband and wife.

Authors:  G M Batty; W E Wilkins; J S Morris
Journal:  Gut       Date:  1994-04       Impact factor: 23.059

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.